Longevity News Weekly Updates

Clinical intelligence hub for longevity, geroscience and healthspan research.

Each week the clinic reviews peer-reviewed literature, clinical trials and geroscience breakthroughs from leading research institutions. The aim is to filter out the noise and translate complex molecular biology into clear, clinician-reviewed education.

Click any weekly briefing to read the full report directly from the clinic’s research archive or the scientific source.

Next update: Monday, November 23, 2026.

Educational research updates only — not medical advice.

This research library is provided for general educational and informational purposes only. It does not recommend, prescribe, endorse, advertise or supply any peptide, drug, supplement, compounded product or longevity intervention. Articles may discuss investigational, preclinical, off-label or emerging research that has not been proven safe or effective for individual patients and may not be approved by the U.S. Food and Drug Administration (FDA) or other health authorities for the uses discussed. Patients must not start, stop or change any treatment based on this page. Personal medical decisions require an individual consultation with an appropriately qualified clinician who can review history, medications, risks, pathology and current evidence.

Longevity · Pinned

🛡️ Oxford Study: Rapamycin Rejuvenates Aging T Cells — June 15, 2026

HealthSpan US research vault

Weekly clinic briefing added to the research vault. This item links to the full data-backed clinic report for doctor review and patient education.

Evidence level: Human data. Published/updated: 2026-06-15.

Clinician note: Clinic briefing. Keep patient wording educational and avoid treatment recommendations unless reviewed by the clinic doctor.

Peptides · Pinned

MOTS-c: mitochondrial-derived peptide research in metabolism, stress and ageing

PubMed-linked review watch

MOTS-c remains an active research topic because mitochondrial-derived peptides may connect metabolic stress, exercise biology and ageing pathways. Current patient-facing framing should stay cautious: interesting biology, not a clinical recommendation.

Evidence level: Review. Published/updated: 2025-01-01.

Clinician note: Discuss only as emerging mitochondrial peptide science. Do not imply availability, suitability or clinical benefit.

GLP-1 · Pinned

GLP-1 medicines and longevity claims: promising mechanisms, but microdosing claims remain unproven

PubMed clinical literature watch

GLP-1 receptor agonists are being discussed in longevity circles because of weight, metabolic and inflammatory mechanisms. The library should clearly separate approved medical uses from unproven longevity or microdosing claims.

Evidence level: Human data. Published/updated: 2025-01-01.

Clinician note: State that any GLP-1 use is a medical decision requiring proper indication, monitoring and risk review.

Peptides

Peptide drug-development tools: predicting peptide lipophilicity and delivery barriers

Open scientific preprint / peptide development methods

New computational approaches are being developed to predict peptide properties such as lipophilicity, which matters because many peptides face stability and delivery barriers. This helps explain why promising peptide biology often does not immediately become safe clinical care.

Evidence level: Computational. Published/updated: 2025-05-22.

Clinician note: Useful as a safety/context article: promising peptide claims need pharmacology, dosing and clinical validation.

Senescence

FOXO4-DRI and senescent-cell targeting: preclinical senolytic peptide research

PubMed senescence research watch

FOXO4-DRI is a synthetic peptide studied as a senescence-targeting strategy in preclinical ageing models. This belongs in the research-news category, not treatment guidance, because translation to patient care remains unresolved.

Evidence level: Preclinical. Published/updated: 2025-01-01.

Clinician note: Use strong investigational language. Avoid patient-use or sourcing discussion.

Peptides

Apelin peptide signalling and muscle ageing

PubMed muscle ageing research watch

Apelin biology is being investigated in relation to muscle ageing, exercise response, mitochondrial function and inflammation. This is useful for patient education about mechanisms, not peptide treatment advice.

Evidence level: Preclinical. Published/updated: 2025-01-01.

Clinician note: Keep the patient takeaway focused on exercise, muscle preservation and research literacy.